- Home
- IMVT vs CVCO Comparison
IMVT vs CVCO Comparison
Compare IMVT & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- CVCO
- Stock Information
- Founded
- IMVT N/A
- CVCO 1965
- Country
- IMVT United States
- CVCO United States
- Employees
- IMVT N/A
- CVCO N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- CVCO Homebuilding
- Sector
- IMVT Health Care
- CVCO Consumer Discretionary
- Exchange
- IMVT Nasdaq
- CVCO Nasdaq
- Market Cap
- IMVT 3.6B
- CVCO 3.8B
- IPO Year
- IMVT N/A
- CVCO N/A
- Fundamental
- Price
- IMVT $21.27
- CVCO $520.73
- Analyst Decision
- IMVT Strong Buy
- CVCO Buy
- Analyst Count
- IMVT 12
- CVCO 2
- Target Price
- IMVT $45.90
- CVCO $487.50
- AVG Volume (30 Days)
- IMVT 1.5M
- CVCO 61.4K
- Earning Date
- IMVT 02-06-2025
- CVCO 01-30-2025
- Dividend Yield
- IMVT N/A
- CVCO N/A
- EPS Growth
- IMVT N/A
- CVCO 2.67
- EPS
- IMVT N/A
- CVCO 20.25
- Revenue
- IMVT N/A
- CVCO $1,927,218,000.00
- Revenue This Year
- IMVT N/A
- CVCO $14.00
- Revenue Next Year
- IMVT N/A
- CVCO $8.80
- P/E Ratio
- IMVT N/A
- CVCO $25.72
- Revenue Growth
- IMVT N/A
- CVCO 4.11
- 52 Week Low
- IMVT $19.07
- CVCO $331.08
- 52 Week High
- IMVT $39.55
- CVCO $544.08
- Technical
- Relative Strength Index (RSI)
- IMVT 47.11
- CVCO 57.20
- Support Level
- IMVT $20.41
- CVCO $514.87
- Resistance Level
- IMVT $21.43
- CVCO $536.95
- Average True Range (ATR)
- IMVT 1.13
- CVCO 13.71
- MACD
- IMVT 0.23
- CVCO -0.99
- Stochastic Oscillator
- IMVT 54.52
- CVCO 45.53
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
About CVCO Cavco Industries Inc. When Issued
Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.